CHICAGO, Nov. 23 /PRNewswire-FirstCall/ -- The Female Health Company (NASDAQ:FHCO) today announced that it will host an investor conference call to discuss its operating results for the quarter and fiscal year ended September 30, 2009 at 11:00 a.m. Eastern Time (EST) on Monday, November 30, 2009. The Company expects to report its FY2009 operating results earlier the same day. Shareholders and other interested parties may participate in the conference call by dialing 800-860-2442 (international participants dial 412-858-4600) and asking to be connected to "The Female Health Company Conference Call", a few minutes before 11:00 a.m. EST on November 30, 2009. A replay of the call will be available one hour after the call through 5:00 p.m. EST on Monday, December 14, 2009 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 435960. About The Female Health Company The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is primarily distributed by public health organizations and donor groups in about 100 countries around the world. Globally, the FC Female Condoms are available in various programs in 116 countries. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in Europe, Canada, Australia, South Africa and the People's Republic of China and are pending in various other countries. FC2 Female Condom® is the only available FDA-approved products controlled by a woman that offer dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. For more information about the Female Health Company visit the Company's website at http://www.femalehealth.com/ and http://www.fc2femalecondom.com/. If you would like to be added to the Company's e-mail alert list, please send an e-mail to . "Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995: The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated. Contacts: William R. Gargiulo, Jr. 231-526-1244 Donna Felch, CFO 312-595-9123 DATASOURCE: The Female Health Company CONTACT: William R. Gargiulo, Jr., +1-231-526-1244, or Donna Felch, CFO, +1-312-595-9123, both for The Female Health Company Web Site: http://www.femalehealth.com/

Copyright